Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly

Age and Ageing

Volumn 37, Issue 4, 2008, Pages 458-461

  Umegaki, Hiroyuki ^a   Kawamura, Takahiko ^b   Mogi, Nanaka ^a   Umemura, Toshitaka ^b   Kanai, Akio ^b   Sano, Takahisa ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHUBU ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGED; BLOOD GLUCOSE MONITORING; BRAIN DAMAGE; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; BRAIN ISCHEMIA; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERINSULINISM; MAGNETIC RESONANCE IMAGING; MALE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 47049129183     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn051     Document Type: Letter

References (25)

1. Cukierman T, Gerstein PC, Williamson JD. Cognitive decline and dementia in DM-systematic overview of prospective observational studies. Diabetologia 2005; 48: 2460-9.
2. Mogi N, Umegaki H, Hattori A et al. Cognitive function in Japanese Elderly with type 2 diabetes mellitus. J Diabetes Complications 2004; 18: 42-6.
3. Strachen MW, Ewing FM, Deary IJ et al. Is type 2 diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care. 1997; 20: 438-45.
4. Croxson SC, Jagger C. Diabetes and cognitive impairment: A community-based study of elderly subjects. Age Ageing 1995; 24: 421-4.
5. Ryan CM, Freed MI, Rood JA et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006; 29: 345-51.
6. Wu JH, Haan MN, Liang J et al. Impact of diabetes on cognitive function among older Latinos: A population-based cohort study. J Clin Epidemiol 2003; 56: 686-93.
7. Geroldi C, Frisoni GB, Paolisso G et al. Insulin resistance in cognitive impairment: The InCHIANTI study. Arch Neurol 2005; 62: 1067-72.
8. Kalmijn S, Feskens EJ, Launer LJ et al. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096-1102.
9. Suzuki M, Umegakii H, Uno T et al. Association between insulin resistance and cognitive function in elderly diabetic patients. Geriatr Gerotol Int 2006; 6: 254-9.
10. Van Harten B, de Leeuw FE, Weinstein HC et al. Brain imaging in patients with diabetes: A systematic review. Diabetes Care 2006; 29: 2539-48.
11. Akisaki T, Sakurai T, Takata T et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22: 376-84.
12. Araki A, Ito H. Asymptomatic cerebral infarction on brain MRI images and cognitive function in elderly diabetic patients. Geriatr Gerotol Int 2002; 2: 206-14.
13. Folstein MF, Folstein SE, McHigh PR. 'Mini-Mental State': A practical method of grading the cognitive function of patients for the clinician. J Psychiatr Res 1978; 12: 189-98.
14. Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19: 448-50.
15. Shinagawa F, Kobayashi S, Fujita K et al. Japanese Manual for the Wechsler Adult Intelligence Scale-Revised. Tokyo: Nihon-bunka-kagaku-sya, 1990; 115-8.
16. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-62.
17. Fazekas F, Chawluk JB, Alavi A et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351.
18. Greene DA, Sima AA, Stevens MJ et al. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-25.
19. Mediratta S, Fozailoff A, Frishman WH. Insulin resistance in systemic hypertension: Pharmacotherapeutic implications. J Clin Pharmacol 1995; 35: 943-56.
20. Hassing LB, Hofer SM, Nilsson SE et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: Evidence from a longitudinal study. Age Ageing 2004; 33: 355-61.
21. Schwartz MW, Figlewicz DP, Baskin DG et al. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992; 13: 387-41.
22. Yu Y, Kastin AJ, Pan W. Reciprocal interactions of insulin and insulin-like growth factor I in receptor-mediated transport across the blood-brain barrier. Endocrinology 2006; 147: 2611-5.
23. Qiu WQ, Folstein MF. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: Review and hypothess. Neurobiol Aging 2006; 27: 190-8.
24. Vermeer SE, Prins ND, Den Heijer T et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 27: 1215-22.
25. Gold G, Kovari E, Herrmann FR et al. Cognitive consequences of thalamic, basal ganglia, and deep white matte lacunes in brain aging and dementia. Stroke 2005; 36: 1184-8.